Evidence map›Paper›PMID 38812802›Full record

ArticleBulletin of the World Health Organization2024

Community tuberculosis screening, testing and care, Uganda.

Stavia Turyahabwe, Muzamiru Bamuloba, Levicatus Mugenyi, Geoffrey Amanya, Raymond Byaruhanga, Joseph Fry Imoko, Mabel Nakawooya, Simon Walusimbi, Jasper Nidoi, Aldomoro Burua and 7 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Community tuberculosis screening, testing and care, Uganda.Bulletin of the World Health Organization · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Stavia TuryahabweNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Muzamiru BamulobaNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Levicatus MugenyiDepartment of Statistics, The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
Geoffrey AmanyaNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Raymond ByaruhangaNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Joseph Fry ImokoDepartment of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
Mabel NakawooyaNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Simon WalusimbiDepartment of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
Jasper NidoiDepartment of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
Aldomoro BuruaNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Moorine SekaddeNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Winters MuttambaDepartment of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
Moses ArinaitweNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Luzze HenryNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Rose KengonziNational TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
Mary MudiopeDepartment of Health Systems Strengthening, Infectious Diseases Institute, Kampala, Uganda.
Bruce J KirengaDepartment of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the effectiveness of a community-based tuberculosis and leprosy intervention in which village health teams and health workers conduct door-to-door tuberculosis screening, targeted screenings and contact tracing. Methods: We conducted a before-and-after implementation study in Uganda to assess the effectiveness of the community tuberculosis intervention by looking at reach, outputs, adoption and effectiveness of the intervention. Campaign 1 was conducted in March 2022 and campaign 2 in September 2022. We calculated percentages of targets achieved and compared case notification rates during the intervention with corresponding quarters in the previous year. We also assessed the leprosy screening. Findings: Over 5 days, campaign 1 screened 1 289 213 people (2.9% of the general population), of whom 179 144 (13.9%) fulfilled the presumptive tuberculosis criteria, and 4043 (2.3%) were diagnosed with bacteriologically-confirmed tuberculosis; 3710 (91.8%) individuals were linked to care. In campaign 2, 5 134 056 people (11.6% of the general population) were screened, detecting 428 444 (8.3%) presumptive tuberculosis patients and 8121 (1.9%) bacteriologically-confirmed tuberculosis patients; 5942 individuals (87.1%) were linked to care. The case notification rate increased from 48.1 to 59.5 per 100 000 population in campaign 1, with a case notification rate ratio of 1.24 (95% confidence interval, CI: 1.22-1.26). In campaign 2, the case notification rate increased from 45.0 to 71.6 per 100 000 population, with a case notification rate ratio of 1.59 (95% CI: 1.56-1.62). Of the 176 patients identified with leprosy, 137 (77.8%) initiated treatment. Conclusion: This community tuberculosis screening initiative is effective. However, continuous monitoring and adaptations are needed to overcome context-specific implementation challenges.

Indexed as

Mass ScreeningTuberculosisAdolescentAdultChildChild, PreschoolCommunity Health ServicesContact TracingFemaleHumansLeprosyMaleMiddle AgedUgandaYoung Adult

Identifiers

PMID38812802
PMCPMC11132162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.